220 related articles for article (PubMed ID: 31493240)
1. Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.
Xicoy H; Brouwers JF; Kalnytska O; Wieringa B; Martens GJM
Mol Neurobiol; 2020 Feb; 57(2):848-859. PubMed ID: 31493240
[TBL] [Abstract][Full Text] [Related]
2. [Synchrotron radiation-based FTIR microspectroscopy study of 6-hydroxydopamine induced Parkinson's disease cell model].
Zhu HY; Pei X; Wu LY; Qi ZM; Wang YY; Liu B; Zhou HG
Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Mar; 33(3):686-9. PubMed ID: 23705433
[TBL] [Abstract][Full Text] [Related]
3. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
[TBL] [Abstract][Full Text] [Related]
4. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of hydralazine on a cellular model of Parkinson's disease: a possible role of hypoxia-inducible factor (HIF)-1α.
Mehrabani M; Nematollahi MH; Tarzi ME; Juybari KB; Abolhassani M; Sharifi AM; Paseban H; Saravani M; Mirzamohammadi S
Biochem Cell Biol; 2020 Jun; 98(3):405-414. PubMed ID: 31940231
[TBL] [Abstract][Full Text] [Related]
6. Lipid levels correlate with neuronal and dopaminergic markers during the differentiation of SH-SY5Y cells.
Marlet FR; Muñoz SS; Sotiraki N; Eliasen JN; Woessmann J; Weicher J; Dreier JE; Schoof EM; Kohlmeier KA; Maeda K; Galvagnion C
Biochim Biophys Acta Mol Basis Dis; 2024 Aug; 1870(6):167212. PubMed ID: 38750771
[TBL] [Abstract][Full Text] [Related]
7. The protective effects of Ramelteon against 6-OHDA-induced cellular senescence in human SH-SY5Y neuronal cells.
Liu D; Gu X; Han F; Cai M; Liu W; Han L; Ma Q
Brain Behav; 2021 Aug; 11(8):e2278. PubMed ID: 34296537
[TBL] [Abstract][Full Text] [Related]
8. Punicalagin Exerts Beneficial Functions in 6-Hydroxydopamine-Treated SH-SY5Y Cells by Attenuating Mitochondrial Dysfunction and Inflammatory Responses.
Chu J; Han W
Med Sci Monit; 2018 Aug; 24():5905-5913. PubMed ID: 30143600
[TBL] [Abstract][Full Text] [Related]
9. Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease.
Kopalli SR; Noh SJ; Koppula S; Suh YH
Neurotoxicology; 2013 Jan; 34():25-32. PubMed ID: 23068419
[TBL] [Abstract][Full Text] [Related]
10. MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway.
Ge H; Yan Z; Zhu H; Zhao H
Exp Mol Pathol; 2019 Aug; 109():16-24. PubMed ID: 31067440
[TBL] [Abstract][Full Text] [Related]
11. Anthraquinone from Edible Fungi Pleurotus ostreatus Protects Human SH-SY5Y Neuroblastoma Cells Against 6-Hydroxydopamine-Induced Cell Death-Preclinical Validation of Gene Knockout Possibilities of PARK7, PINK1, and SNCA1 Using CRISPR SpCas9.
J B; Das A; Sakthivel KM
Appl Biochem Biotechnol; 2020 Jun; 191(2):555-566. PubMed ID: 31820379
[TBL] [Abstract][Full Text] [Related]
12. 3,4-dihydroxybenzalacetone protects against Parkinson's disease-related neurotoxin 6-OHDA through Akt/Nrf2/glutathione pathway.
Gunjima K; Tomiyama R; Takakura K; Yamada T; Hashida K; Nakamura Y; Konishi T; Matsugo S; Hori O
J Cell Biochem; 2014 Jan; 115(1):151-60. PubMed ID: 23959789
[TBL] [Abstract][Full Text] [Related]
13. Induction of cross-tolerance between protective effect of morphine and nicotine in 6-hydroxydopamine-induce neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Elyasi L; Eftekhar-Vaghefi SH; Asadi-Shekaari M; Esmaeili-Mahani S
Int J Neurosci; 2019 Feb; 129(2):129-138. PubMed ID: 29947270
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the neuroprotective potential of caffeic acid phenethyl ester in a cellular model of Parkinson's disease.
Turan D; Abdik H; Sahin F; Avşar Abdik E
Eur J Pharmacol; 2020 Sep; 883():173342. PubMed ID: 32634439
[TBL] [Abstract][Full Text] [Related]
15. Maackiain Ameliorates 6-Hydroxydopamine and
Tsai RT; Tsai CW; Liu SP; Gao JX; Kuo YH; Chao PM; Hung HS; Shyu WC; Lin SZ; Fu RH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32585871
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
Ko YH; Kwon SH; Kim SK; Lee BR; Hur KH; Kim YJ; Kim SE; Lee SY; Jang CG
Arch Pharm Res; 2019 Dec; 42(12):1081-1091. PubMed ID: 31705299
[TBL] [Abstract][Full Text] [Related]
17. Eucommia ulmoides Oliv. bark. attenuates 6-hydroxydopamine-induced neuronal cell death through inhibition of oxidative stress in SH-SY5Y cells.
Kwon SH; Ma SX; Hong SI; Kim SY; Lee SY; Jang CG
J Ethnopharmacol; 2014 Feb; 152(1):173-82. PubMed ID: 24440915
[TBL] [Abstract][Full Text] [Related]
18. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
[TBL] [Abstract][Full Text] [Related]
19. Edible bird's nest ameliorates oxidative stress-induced apoptosis in SH-SY5Y human neuroblastoma cells.
Yew MY; Koh RY; Chye SM; Othman I; Ng KY
BMC Complement Altern Med; 2014 Oct; 14():391. PubMed ID: 25308934
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV Protects 6-Hydroxydopamine-Induced SH-SY5Y Cell Model of Parkinson's Disease via Activating the JAK2/STAT3 Pathway.
Xu Z; Yang D; Huang X; Huang H
Front Neurosci; 2021; 15():631501. PubMed ID: 33833662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
